BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 24794896)

  • 1. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
    Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K
    J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
    Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
    J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms.
    Birk SE; Boisen A; Nielsen LH
    Adv Drug Deliv Rev; 2021 Jul; 174():30-52. PubMed ID: 33845040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted, triggered drug delivery to tumor and biofilm microenvironments.
    Benoit DS; Koo H
    Nanomedicine (Lond); 2016 Apr; 11(8):873-9. PubMed ID: 26987892
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver nanoparticles as an alternative strategy against bacterial biofilms.
    Markowska K; Grudniak AM; Wolska KI
    Acta Biochim Pol; 2013; 60(4):523-30. PubMed ID: 24432308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic polymeric nanoparticles for biofilm-associated infection therapy.
    Cheow WS; Hadinoto K
    Methods Mol Biol; 2014; 1147():227-38. PubMed ID: 24664837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections.
    Abed N; Couvreur P
    Int J Antimicrob Agents; 2014 Jun; 43(6):485-96. PubMed ID: 24721232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoengineered drug delivery systems for enhancing antibiotic therapy.
    Kalhapure RS; Suleman N; Mocktar C; Seedat N; Govender T
    J Pharm Sci; 2015 Mar; 104(3):872-905. PubMed ID: 25546108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes and lipid carriers in the treatment of microbial infections.
    Bakker-Woudenberg IA; Lokerse AF
    Scand J Infect Dis Suppl; 1990; 74():34-41. PubMed ID: 2097717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing Bacterial Infections and Biofilm Formation Using Nanoparticles and Nanostructured Antibacterial Surfaces.
    Mi G; Shi D; Wang M; Webster TJ
    Adv Healthc Mater; 2018 Jul; 7(13):e1800103. PubMed ID: 29790304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.
    Alabresm A; Chandler SL; Benicewicz BC; Decho AW
    Bioconjug Chem; 2021 Aug; 32(8):1411-1430. PubMed ID: 34319073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro.
    Cai J; Huang H; Song W; Hu H; Chen J; Zhang L; Li P; Wu R; Wu C
    Int J Pharm; 2015 Nov; 495(2):728-37. PubMed ID: 26417849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections.
    Tamilvanan S; Venkateshan N; Ludwig A
    J Control Release; 2008 May; 128(1):2-22. PubMed ID: 18342974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial efficacy of inhalable antibiotic-encapsulated biodegradable polymeric nanoparticles against E. coli biofilm cells.
    Cheow WS; Chang MW; Hadinoto K
    J Biomed Nanotechnol; 2010 Aug; 6(4):391-403. PubMed ID: 21323113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment.
    Colilla M; Vallet-Regí M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of liposomes to deliver bactericides to bacterial biofilms.
    Jones MN
    Methods Enzymol; 2005; 391():211-28. PubMed ID: 15721384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.